ArticleTranslational lung cancer research2025

Comparison of the effectiveness of alectinib versus crizotinib followed by alectinib in patients with ALK-positive advanced non-small-cell lung cancer in real-world setting and in the ALEX study.

Xue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.